RAD51 GENE MUTATION

Clinical trials for RAD51 GENE MUTATION explained in plain language.

Never miss a new study

Get alerted when new RAD51 GENE MUTATION trials appear

Sign up with your email to follow new studies for RAD51 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Terminated 1

New hope: targeted drug olaparib shows promise for Hard-to-Treat breast cancers

Disease control Ongoing

This study tests a drug called olaparib in people with metastatic breast cancer that has spread beyond the breast. Participants must have a specific gene mutation that makes their cancer cells less able to repair DNA damage. The goal is to see if olaparib can shrink tumors or slo…

Matched conditions: RAD51 GENE MUTATION

Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control

Last updated May 11, 2026 20:53 UTC

RAD51 GENE MUTATION

Get alerted when new RAD51 GENE MUTATION trials appear

New hope: targeted drug olaparib shows promise for Hard-to-Treat breast cancers